Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3046861	-legi-o	— (—)	211	230	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Pneumonia, organism unspecified

146

28.61

170.53

1.1

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

140

24.04

151.97

1.1

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

140

23.70

149.67

1.1

1.0

—

All pneumoniae

140

23.05

147.92

1.1

1.0

—

Influenza and pneumonia

137

22.01

137.45

1.1

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

132

25.12

132.76

1.1

1.0

—

132

25.12

132.76

1.1

1.0

—

COPD/asthma/ILD related infections

12.15

52.30

1.1

1.0

—

COPD/asthma related infections

12.15

52.30

1.1

1.0

—

Other respiratory diseases principally affecting the interstitium

13.29

43.35

1.1

1.0

—

Other interstitial pulmonary diseases

14.89

41.64

1.1

1.0

—

Interstitial lung disease

14.31

40.76

1.1

1.0

—

Interstitial lung disease endpoints

14.31

40.76

1.1

1.0

—

Fever of other and unknown origin

7.17

40.00

1.1

—

ILD, hospital admissions

13.93

39.05

1.1

1.0

—

Bacterial pneumoniae

12.81

37.70

1.2

1.0

—

Bacterial pneumonia (organism specified)

7.46

36.39

1.1

—

Oral corticosteroids

109

5.00

34.86

1.1

—

ILD, hospital admissions 1, main diag only

13.55

33.08

1.1

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

60.66

31.09

1.1

1.0

—

ILD, hospital admission 2, with pulmonary infections

60.55

31.08

1.1

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.74

29.55

1.1

—

Bacterial infection, other or unspecified

5.70

27.75

1.2

1.1

—

ILD medications: immunosuppressive drugs

5.74

26.44

1.1

—

Other bacterial diseases

118

4.34

25.97

1.1

—

Asthma, unspecified (mode), excluding more controls

15.71

25.85

1.2

1.0

—

First line medication for Crohn's disease

4.64

25.42

1.1

—

Other pulmonary diagnosis

10.02

25.03

1.0

—

ILD medications

4.33

24.86

1.1

—

Inflammatory bowel disease treatment related agents

109

4.17

24.79

1.1

—

Excluding asthma or asthma-COPD overlap

9.78

24.11

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

7.82

23.36

1.1

1.0

—

Asthma, excluding more controls

12.09

23.21

1.2

1.0

—

COPD differential diagnosis

9.55

23.21

1.0

—

ILD differential diagnosis

9.54

23.21

1.0

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

27.95

23.12

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

12.32

22.99

1.1

1.0

—

COPD (mode)

12.16

22.86

1.2

1.0

—

Asthma

9.45

22.30

1.2

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

7.13

21.59

1.1

1.0

—

Asthma, unspecified (mode)

10.85

21.39

1.2

1.0

—

Implicit bacterial Sepsis

5.65

20.94

1.1

1.0

—

Bacterial Sepsis

5.16

20.69

1.1

—

Other septicaemia

6.00

20.52

1.1

1.0

—

Septicaemia

5.52

20.29

1.2

1.0

—

Asthma (only as main-diagnosis)

8.91

19.34

1.1

1.0

—

Bacterial pneumonia, not elsewhere classified

8.53

19.25

1.2

1.0

—

Asthma (mode)

8.63

19.11

1.2

1.0

—

Explicit Sepsis

5.13

18.73

1.2

1.0

—

Acute renal failure

7.45

18.21

1.1

1.0

—

Implicit Sepsis

108

3.96

18.07

1.1

—

Asthma-related pneumonia

5.22

17.88

1.2

1.1

—

Agranulocytosis

14.59

17.61

1.1

1.0

—

Asthma-related pneumonia or sepsis

5.14

17.60

1.2

1.1

—

Asthma, hospital admissions 3, pneumonia

5.14

17.60

1.2

1.1

—

Covid-19 confirmed case

6.31

17.52

1.3

1.0

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

10.59

17.32

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

138

3.33

16.06

1.1

—

Second line medication for Crohn's disease

4.23

15.90

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

118

3.51

15.57

1.1

—

L04AX Other immunosuppressants

4.17

15.24

1.0

1.1

—

Renal failure

4.26

15.23

1.1

1.0

—

Non-follicular lymphoma, hilmo, excluding all cancers

12.55

15.14

1.1

1.0

—

Early onset COPD, excluding more controls

12.51

15.12

1.3

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

5.24

15.12

1.2

1.1

—

Diagnoses used for exclusion with ILD

5.92

14.76

1.1

1.0

—

COPD, hospital admission 2, with asthma infections

4.95

14.67

1.2

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

4.99

14.51

1.2

1.1

—

Diseases of the respiratory system

7.80

14.41

1.0

—

Lung diseases due to external agents

7.94

14.01

1.2

1.0

—

Provisional assignment of new diseases of uncertain etiology

4.58

13.72

1.3

1.1

—

Codes for special purposes

4.58

13.72

1.3

1.1

—

Acute bronchitis

4.55

13.54

1.3

1.1

—

Hypo-osmolality and hyponatraemia

6.56

13.12

1.1

—

Renal tubulo-interstitial diseases

134

3.15

13.01

1.1

—

Heart failure, not strict

106

3.32

12.69

1.2

1.0

—

Non-follicular lymphoma

9.41

12.54

1.1

1.0

—

Heart failure and antihypertensive medication

8.27

12.49

1.1

—

Other diseases of blood and blood-forming organs, wide

5.80

12.24

1.1

1.0

—

Other and unspecified anaemias

3.97

12.07

1.0

1.1

—

Lung cancer and mesothelioma

9.88

12.04

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

4.40

11.86

1.0

—

Contact with and exposure to communicable diseases

6.53

11.84

1.2

1.0

—

Presence of other functional implants

3.50

11.70

1.2

1.1

—

Other anaemias

3.86

11.64

1.0

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

4.45

11.63

1.1

1.0

—

Viral pneumonia

22.92

11.55

1.3

1.0

—

Aplastic and other anaemias

3.67

11.44

1.0

1.1

—

Pulmonary heart disease

4.57

11.15

1.2

1.1

—

Pulmonary embolism

4.57

11.15

1.2

1.1

—

Polyarthropathies

3.26

11.08

1.0

1.1

—

Later onset COPD, excluding more controls

8.33

10.91

1.1

1.0

—

All influenza

9.29

10.75

1.0

—

Persons with potential health hazards related to communicable diseases

5.34

10.73

1.2

1.0

—

Other diseases of pleura

3.55

10.70

1.2

1.1

—

Drug-induced neutropenia

21.54

10.67

1.1

1.0

—

Other acute lower respiratory infections

3.52

10.49

1.3

1.1

—

Reimbursement for rheumatic diseases

101

3.46

10.35

1.0

—

Invasive ventilation

11.04

10.16

1.0

—

Other specified/unspecified arthritis

4.79

9.99

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

100

3.25

9.99

1.2

1.1

—

Dyspnoea

144

2.77

9.95

1.1

—

Chronic kidney disease

4.43

9.92

1.1

—

ILD medications: azathioprine

9.24

9.87

1.1

1.0

—

Non-invasive ventilation

7.74

9.83

1.1

1.0

—

General symptoms and signs

100

2.81

9.68

1.0

1.1

—

Non-ischemic cardiomyopathy

4.89

9.57

1.0

1.1

—

Other arthritis (FG)

4.43

9.53

1.0

1.1

—

COPD

3.36

9.44

1.2

1.1

—

Azathioprine

8.58

9.34

1.1

1.0

—

Enlarged lymph nodes

8.58

9.34

1.1

1.0

—

Asthma-related infections

112

3.16

9.26

1.2

1.1

—

Asthma, hospital admission 2, infections

112

3.16

9.26

1.2

1.1

—

Abnormalities of breathing

103

2.83

9.10

1.1

—

Other diseases of the respiratory system

5.01

9.08

1.3

1.0

—

Other respiratory disorders and diseases

5.01

9.08

1.3

1.0

—

3.88

8.73

1.3

1.0

—

Adjustment and management of implanted device

5.01

8.60

1.1

—

Implicit viral Sepsis

5.53

8.49

1.1

1.0

—

Viral Sepsis

5.53

8.49

1.1

1.0

—

Heart failure,strict

3.12

8.14

1.1

1.0

—

All-cause Heart Failure

2.90

8.04

1.1

1.0

—

Glomerular diseases

5.56

8.01

1.1

1.0

—

Chronic lower respiratory diseases

139

2.37

7.94

1.1

—

Other viral diseases

5.15

7.88

1.4

1.0

—

Venous thromboembolism

112

2.95

7.80

1.1

—

COPD, hospital admissions

3.04

7.70

1.2

1.1

—

Other chronic obstructive pulmonary disease

3.10

7.67

1.2

1.1

—

L04AD Calcineurin inhibitors

8.35

7.58

1.2

1.0

—

Tumor necrosis factor alpha inhibitors

7.34

7.55

1.0

—

Persons encountering health services in other circumstances

3.58

7.54

1.3

1.0

—

Spondylosis

104

2.89

7.53

1.1

—

DVT of lower extremities and pulmonary embolism

3.14

7.46

1.1

—

COPD, early/later onset

2.97

7.40

1.2

1.1

—

Exclusions for E4_PCOS_BROAD

5.91

7.36

1.1

1.0

—

Heart failure, strict

2.76

7.24

1.1

1.0

—

Certain disorders involving the immune mechanism

5.39

7.24

1.2

1.0

—

Biological medication for rheuma

6.88

7.14

1.0

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

20.12

7.13

1.0

—

Diffuse large B-cell lymphoma, helper endpoint

20.12

7.13

1.0

—

Seronegative rheumatoid arthritis

7.71

7.12

1.0

1.1

—

Enterocolitis due to Clostridium difficile

7.71

7.12

1.1

1.0

—

Malaise and fatigue

3.34

7.03

1.1

—

Suppurative and necrotic conditions of lower respiratory tract

13.82

6.89

1.2

1.0

—

Valvular heart disease excluding rheumatic fever

3.20

6.85

1.1

—

Non-allergic asthma (mode)

13.63

6.84

1.2

1.0

—

Non-rheumatic valve diseases

3.20

6.83

1.1

—

Malignant neoplasm

103

2.53

6.78

1.1

—

Abnormal spermatozoa

5.43

6.76

1.0

—

Heart failure and bmi 25plus

3.21

6.54

1.1

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

4.83

6.44

1.0

—

Bronchitis

148

2.26

6.37

1.2

1.1

—

Pneumonia due to Haemophilus influenzae

+∞

6.30

1.0

0.0

—

Osteopathies and chondropathies

103

2.76

6.16

1.2

1.0

—

COPD related to multimorbidity

2.91

6.14

1.3

1.0

—

Rheumatoid arthritis, including avohilmo

3.20

6.13

1.0

1.1

—

Dialysis, with operation codes

5.80

6.10

1.1

1.0

—

Other (seronegative) rheumatoid arthritis, wide

4.82

5.97

1.0

—

Any event in cancer register

107

2.38

5.90

1.1

—

Spondylopathies

114

2.34

5.87

1.1

—

Cutaneous abscess, furuncle and carbuncle

4.17

5.81

1.1

1.0

—

Thrombocytopenia, unspecified

11.15

5.79

1.0

—

COPD-related respiratory insufficiency

5.01

5.74

1.2

1.0

—

Autoimmune diseases excluding thyroid diseases

122

2.23

5.71

1.1

—

Purpura and other haemorrhagic conditions

5.89

5.62

1.0

—

Atrial fibrillation and flutter with reimbursement

4.58

5.59

1.1

1.0

—

All influenza (not pneumonia)

12.87

5.57

1.0

—

L04AA Selective immunosuppressants

4.25

5.55

1.1

1.0

—

Disorders of other endocrine glands

3.05

5.44

1.0

1.1

—

Sulfasalazine

3.95

5.43

1.0

1.1

—

Atrial fibrillation and flutter

4.18

5.43

1.1

1.0

—

Certain infectious and parasitic diseases

2.41

5.39

1.0

—

Infections, IBD-co-morbidities

5.73

5.36

1.1

1.0

—

Use of hypnotics and sedatives

140

2.11

5.29

1.1

—

Autoimmune diseases

122

2.14

5.28

1.1

—

Chronic periapical parodontitis

3.85

5.25

1.3

1.1

—

Early onset COPD

3.85

5.25

1.3

1.0

—

Autoimmune diseases related-to ILD

141

2.31

5.24

1.1

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2.84

5.22

1.0

—

Haemorrhage from respiratory passages

3.05

5.12

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2.79

5.05

1.0

—

Injury of muscle and tendon at lower leg level

5.27

5.03

1.0

—

Care involving dialysis

10.03

5.02

1.1

1.0

—

Pacemaker

2.96

4.94

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

120

2.14

4.91

1.1

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

3.79

4.91

1.1

—

Other necrotizing vasculopathies (FG)

11.46

4.78

1.0

—

Exposure to unspecified factor

164

2.08

4.78

1.1

—

Hypokalaemia

5.01

4.77

1.3

1.1

—

Nephropathy related operations

5.01

4.77

1.1

1.0

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2.27

4.75

1.1

—

Malignant neoplasm, wide definition for exclusion

2.27

4.75

1.1

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2.27

4.75

1.1

—

129

2.05

4.75

1.2

1.1

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2.74

4.73

1.0

—

Persons encountering health services for specific procedures and health care

146

2.04

4.69

1.1

—

Sleep apnoea

143

2.09

4.68

1.2

1.1

—

Osteoporosis

3.39

4.66

1.2

1.0

—

Anaemias

8.32

4.63

1.1

1.0

—

Sleep apnoea, including avohilmo

142

2.06

4.57

1.2

1.1

—

Pneumonitis due to solids and liquids

8.20

4.56

1.0

—

Glomerulonephritis

8.20

4.56

1.1

1.0

—

Herpesviral [herpes simplex] infections

8.19

4.56

1.0

—

Secondary hypertension

13.89

4.55

1.0

—

Disorders of calcium metabolism

10.03

4.52

1.0

—

Other necrotizing vasculopathies

10.03

4.52

1.0

—

Streptococcal septicaemia

10.02

4.52

1.1

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

3.36

4.44

1.1

—

Personality disorders

4.00

4.43

1.4

1.0

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2.53

4.41

1.0

1.1

—

3.58

4.40

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

138

2.07

4.39

1.1

—

Ischemic heart diseases

110

2.16

4.35

1.2

1.1

—

Rheumatoid arthritis

2.93

4.35

1.0

1.1

—

Acute tubulo-interstitial nephritis

110

2.34

4.29

1.2

1.0

—

Pyogenic arthritis

11.69

4.27

1.1

1.0

—

Adalimumab

11.69

4.27

1.0

—

Low back pain

124

2.17

4.26

1.2

1.1

—

Ischaemic heart disease, wide definition

111

2.14

4.26

1.2

1.1

—

Other or unspecified ileus, impaction or obstruction

3.87

4.25

1.3

1.0

—

Abnormal findings on diagnostic imaging of lung

111

2.37

4.19

1.2

1.1

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

4.15

4.18

1.2

1.1

—

Other heart diseases, wide

107

2.15

4.16

1.1

—

Disorders of mineral metabolism

6.94

4.16

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

141

2.17

4.15

1.2

1.1

—

Sleep disorders (combined)

145

1.99

4.14

1.2

1.1

—

Obesity related asthma

2.98

4.11

1.2

1.0

—

Oxycodone

2.73

4.10

1.2

1.1

—

Hernia of abdominal wall, postoperative

4.35

4.08

1.1

1.0

—

Cardiomyopathy

4.35

4.08

1.1

1.0

—

Other heart diseases

3.05

4.06

1.2

1.0

—

Methotrexate

6.44

3.98

1.0

1.1

—

Other bacterial intestinal infections

3.93

3.97

1.1

1.0

—

Bacterial intestinal infections, IBD co-morbidities

3.93

3.97

1.1

1.0

—

Other medical care

2.60

3.95

1.0

1.1

—

Personality disorders, excluding more controls

3.64

3.91

1.4

1.0

—

Non-selective monoamine reuptake inhibitors

2.62

3.83

1.3

1.0

—

COPD, hospital admissions 1, only main diagnosis

2.59

3.83

1.2

1.1

—

FESS (DNB20)

6.01

3.81

1.0

—

Other/unspecified dorsalgia

2.66

3.77

1.2

1.0

—

Other and unspecified drugs and medicaments

8.77

3.77

1.1

1.0

—

GASTRO-related operations

2.51

3.72

1.0

—

Any gastric operation

2.51

3.72

1.0

—

Asthma/COPD (KELA code 203)

139

1.98

3.70

1.2

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

108

2.15

3.70

1.2

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

119

0.27

3.69

1.0

1.1

—

Aortic aneurysm

3.01

3.68

1.4

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

103

2.00

3.67

1.0

1.1

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

6.68

3.67

1.0

—

Transplanted organ and tissue status

6.68

3.67

1.3

1.0

—

Dentinal caries

3.24

3.59

1.4

1.1

—

Metabolic disorders

136

1.92

3.58

1.2

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

7.79

3.56

1.1

1.0

—

Tramadol

106

2.06

3.54

1.1

—

Emphysema

6.17

3.50

1.4

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.16

3.50

1.1

1.0

—

Other and unspecified psoriasis

10.02

3.49

1.0

—

Emotionally unstable personality disorder

10.01

3.49

1.3

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

3.85

3.48

1.3

1.0

—

Basal cell carcinoma, including avohilmo

107

2.13

3.45

1.0

1.1

—

Systemic connective tissue disorders

2.66

3.38

1.0

—

Codeine

110

1.95

3.38

1.1

—

Diseases of pulp and periapical tissues

2.50

3.37

1.2

1.1

—

Ethmoidectomy

5.01

3.36

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

7.01

3.36

1.6

1.0

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

3.36

3.33

1.3

1.0

—

Other fall from one level to another

3.44

3.32

1.0

—

Basal cell carcinoma

105

2.13

3.32

1.0

1.1

—

Used for control exclusion in common control thyroid runs

116

1.88

3.31

1.0

1.1

—

Extracorporeal dialysis

8.59

3.26

1.0

—

Brachial plexus disorders

8.58

3.26

1.0

—

Codeine or tramadol medication

149

1.78

3.23

1.1

—

Pleural effusion

3.58

3.19

1.1

1.0

—

Explicit bacterial Sepsis

5.34

3.19

1.1

1.0

—

Lower back pain or/and sciatica

165

1.81

3.18

1.1

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2.46

3.17

1.1

1.0

—

Poisoning by medicine

4.50

3.11

1.1

1.0

—

Later onset COPD

2.53

3.10

1.1

—

Other viral diseases, not elsewhere classified

4.49

3.10

1.6

1.0

—

Dental caries

2.93

3.07

1.4

1.0

—

Finngen Rheumatological endpoints

119

1.87

3.06

1.1

—

Non-small cell lung cancer

3.24

3.05

1.2

1.0

—

Cardiomyopathy, other and unspecified

7.51

3.05

1.2

1.0

—

Suicide or other Intentional self-harm

3.45

3.04

1.2

1.0

—

Acute sinusitis

2.33

3.04

1.1

—

Toxic effects of substances chiefly nonmedicinal as to source

5.84

3.02

1.0

—

Hypothyroidism and >3 levothyroxin purchases

5.75

3.01

1.0

—

Hypothyroidism, levothyroxine purchases

5.75

3.01

1.0

—

Asthma (diagnoses ohter than nonallergic)

166

1.85

3.01

1.2

1.1

—

Hypothyroidism (congenital or acquired)

5.75

3.01

1.0

—

Seropositive rheumatoid arthritis, strict definition

4.29

2.99

1.0

—

Poisoning by drugs, medicaments and biological substances

4.29

2.99

1.1

1.0

—

Cardiodefibrillation

2.30

2.98

1.2

1.0

—

Opioids

110

1.86

2.98

1.1

—

Allergic urticaria

10.01

2.98

1.0

—

Fracture at wrist and hand level

2.74

2.97

1.1

1.0

—

Other CVD

3.00

2.96

1.3

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

104

2.05

2.95

1.0

1.1

—

Coronary atherosclerosis

1.99

2.92

1.2

1.1

—

Glomerular disorders in diseases classified elsewhere

4.71

2.91

1.1

1.0

—

Cardiac arrhythmias

2.36

2.91

1.1

—

Disorders of adult personality and behaviour

3.33

2.90

1.2

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

128

1.99

2.90

1.1

—

Disorders of refraction and accommodation

3.32

2.88

1.0

—

Idiopathic pulmonary fibrosis

5.40

2.87

1.1

1.0

—

Other complications of surgical and medical care, not elsewhere classified

6.67

2.86

1.2

1.0

—

Oedema, not elsewhere classified

2.91

2.82

1.2

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.72

2.82

1.1

—

Syncope and collapse

2.43

2.81

1.0

1.1

—

Chronic sinusitis

2.34

2.80

1.1

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.00

2.80

0.0

1.1

—

Gout, strict definition

3.06

2.80

1.0

—

Hypothyroidism, drug reimbursement

7.15

2.79

1.0

—

Secondary uncertain malignant neoplasm

3.92

2.77

1.1

1.0

—

Examination and observation for other reasons

118

0.31

2.77

1.2

1.1

—

Dorsalgia

125

1.78

2.76

1.1

—

Kidney transplant status

8.35

2.75

1.2

1.0

—

Nail disorders

8.34

2.75

1.0

—

Scoliosis

8.34

2.75

1.2

1.0

—

Other specified and unspecified personality disorders

8.34

2.75

1.2

1.0

—

L02BG Aromatase inhibitors

2.86

2.74

1.2

1.0

—

Persons encountering health services in other circumstances, wide

151

1.68

2.73

1.1

—

Volume depletion

5.01

2.72

1.4

1.0

—

Mucosal proctocolitis

5.00

2.72

1.4

1.0

—

Asthma, including avohilmo

162

1.69

2.70

1.2

1.1

—

Paralytic ileus and intestinal obstruction

2.59

2.69

1.3

1.1

—

Other retinal disorders

116

1.94

2.67

1.0

1.1

—

Thoracic aortic aneurysm

3.75

2.67

1.1

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3.13

2.64

1.2

1.0

—

Sequelae of external causes of morbidity and mortality

2.79

2.64

1.3

1.0

—

Other cataract

2.21

2.64

1.1

1.0

—

Seropositive rheumatoid arthritis

2.79

2.63

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

2.69

2.61

1.2

1.0

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

2.69

2.61

1.2

1.0

—

L01XE Protein kinase inhibitors

7.16

2.55

1.0

—

Persons encountering health services for specific procedures, not carried out

7.15

2.55

1.2

1.0

—

Non-allergic asthma

7.15

2.55

1.2

1.0

—

Gout

2.44

2.53

1.0

1.1

—

Sequelae with surgical and medical care as external cause

3.03

2.52

1.4

1.0

—

Allergic asthma (mode)

7.01

2.51

1.2

1.0

—

Calcific aortic valvular stenosis

2.34

2.50

1.1

—

Calcific aortic valvular stenosis, operated

2.34

2.50

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

2.34

2.50

1.1

—

Operations 2 for CAVS

2.34

2.50

1.1

—

Depression medications

4.47

2.47

1.1

1.0

—

Somatoform disorder

4.38

2.47

1.1

1.0

—

Psoriasis

2.67

2.44

1.0

—

Pregnancy hypertension

0.00

2.43

0.0

1.1

—

Calcific aortic valvular stenosis, including rheumatic fever

2.30

2.43

1.1

—

Fracture of foot, except ankle

2.94

2.41

1.1

1.0

—

Hypotension

2.94

2.41

1.4

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

5.01

2.40

1.2

1.0

—

5.00

2.40

1.2

1.0

—

Malignant neoplasm of bronchus and lung

2.78

2.38

1.2

1.0

—

Diseases of the skin and subcutaneous tissue

121

1.70

2.38

1.0

1.1

—

Reactive arthropathies

6.26

2.37

1.0

—

Myopia

6.25

2.37

1.0

—

Gout, unspecified

2.75

2.37

1.0

—

Peritonsillar abscess

3.64

2.36

1.0

—

Other pleural conditions

4.12

2.36

1.0

—

Other/unspecified rheumatoid arthritis

4.12

2.36

1.0

1.1

—

Myocardial infarction

1.96

2.33

1.2

1.0

—

Gout, FINNGEN

2.31

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2.86

2.30

1.2

1.0

—

Type 2 diabetes, wide definition

127

1.74

2.30

1.1

—

Hypothyroidism, strict autoimmune

100

1.85

2.29

1.1

—

Gonarthrosis [arthrosis of knee](FG)

101

1.81

2.29

1.1

—

In situ neoplasms

2.39

2.29

1.0

—

Nausea and vomiting

2.57

2.28

1.1

1.0

—

Problems related to lifestyle

4.62

2.27

1.2

1.0

—

Other disorders of bladder

3.48

2.27

1.4

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2.55

2.26

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

2.57

2.25

1.2

1.0

—

Intestinal infectious diseases

166

1.69

2.25

1.1

—

Bleeding

144

1.72

2.23

1.1

—

Other CVD (FINNGEN)

4.73

2.22

1.7

1.0

—

Pain, not elsewhere classified

3.10

2.22

1.1

—

Pneumothorax

5.56

2.21

1.0

—

Viral warts

5.56

2.21

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

120

1.76

2.19

1.2

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

131

1.71

2.18

1.1

—

Nerve, nerve root and plexus disorders

163

1.62

2.17

1.1

—

Injuries to the thorax

2.02

2.15

1.1

—

Asthma, hospital admissions , main diagnosis only

161

1.72

2.15

1.1

—

AV-block

3.03

2.14

1.2

1.0

—

Hypothyroidism, other/unspecified

127

1.72

2.13

1.1

—

Other/unspecified seropositive rheumatoid arthritis

2.45

2.10

1.0

—

Seropositive rheumatoid arthritis, wide

2.45

2.10

1.0

—

Substance use, excluding alcohol

3.20

2.09

1.5

1.0

—

Vocal cord dysfunction

5.16

2.09

1.0

—

2.22

2.08

1.0

1.1

—

Parasetamol

1.87

2.08

1.0

1.1

—

Sensorineural hearing loss

131

1.71

2.07

1.2

1.1

—

Hyperkalaemia

5.01

2.07

1.0

—

Intestinal stricture

2.26

2.07

1.3

1.0

—

Benign neoplasm: Caecum

5.01

2.07

1.0

—

Pruritus

5.00

2.07

1.2

1.0

—

Sarcoidosis

3.50

2.05

1.1

1.0

—

Malignant neoplasm of skin

114

1.78

2.04

1.0

1.1

—

Unspecified kidney failure

4.00

2.04

1.0

—

Rheumatism, unspecified

4.00

2.04

1.2

1.1

—

Unspecified acute lower respiratory infection

4.00

2.04

1.2

1.0

—

Inflammatory bowel disease

2.40

2.02

1.2

1.0

—

Headache

1.99

2.00

1.1

—

Diseases of arteries, arterioles and capillaries

125

1.73

1.99

1.2

1.0

—

Bipolar affective disorders

3.34

1.96

1.1

1.0

—

Nonorganic sleeping disorders, excluding more controls

3.34

1.96

1.7

1.0

—

Malignant neoplasm of breast, HER-positive

2.37

1.96

1.3

1.0

—

Conductive and sensorineural hearing loss

132

1.68

1.96

1.2

1.1

—

Major coronary heart disease event

117

1.71

1.95

1.2

1.1

—

Bronchiectasis

4.55

1.94

1.0

—

Persistent mood disorders

2.96

1.93

1.5

1.0

—

Insomnia

3.75

1.93

1.8

1.0

—

Degeneration of macula and posterior pole

1.88

1.91

1.0

1.1

—

Coronary revascularization (ANGIO or CABG)

1.87

1.91

1.1

1.0

—

Fall on same level

154

1.56

1.90

1.1

—

Other antidepressants

131

1.59

1.90

1.2

1.1

—

Fracture of rib(s), sternum and thoracic spine

2.24

1.90

1.1

1.0

—

Iron deficiency anaemia

2.00

1.90

1.1

—

Noninfective enteritis and colitis

2.00

1.89

1.2

1.1

—

Coxarthrosis [arthrosis of hip](FG)

1.83

1.88

1.2

1.1

—

Valvular operations

3.18

1.88

1.0

—

Acute appendicitis, with complications

2.65

1.86

1.1

1.0

—

Other diseases of liver

2.86

1.86

1.0

—

Zoster [herpes zoster]

2.86

1.86

1.1

1.0

—

Medicines for HER+ breast cancer

2.29

1.84

1.2

1.0

—

Hydronephrosis

3.53

1.83

1.0

—

Ulcerative colitis, NAS

3.53

1.83

1.5

1.0

—

Other and unspecified nonorganic psychotic disorders

3.53

1.83

1.5

1.0

—

Delirium, not induced by alcohol and other psychoactive substances

3.53

1.83

1.2

1.0

—

Suggestive for eosinophilic asthma

4.17

1.82

1.0

—

Gout, idiopatic and unspecified

2.27

1.80

1.0

1.1

—

Ulcerative colitis

2.57

1.80

1.3

1.0

—

Duodenal ulcer

3.05

1.80

1.0

—

5-aminosalicylic acid

3.04

1.79

1.4

1.0

—

Major coronary heart disease event excluding revascularizations

114

1.70

1.79

1.2

1.1

—

Myocardial infarction, unclassifiable

2.28

1.79

1.1

—

Urticaria and erythema

2.17

1.77

1.2

1.1

—

Appendectomy

119

1.78

1.76

1.2

1.0

—

Monoamine oxidase A inhibitors

3.34

1.74

1.3

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

3.34

1.74

1.2

1.1

—

Other and unspecified tonsillitis

2.71

1.72

1.1

1.0

—

Specific personality disorders

2.92

1.72

1.3

1.0

—

Superficial injury of hip and thigh

2.92

1.72

1.0

—

Budesonide

3.85

1.71

1.0

—

Intracranial trauma

1.84

1.71

1.1

—

Acute appendicitis

146

1.68

1.71

1.2

1.1

—

Schizophrenia or delusion

2.29

1.70

1.4

1.0

—

Gastroduodenal ulcer

2.13

1.70

1.1

—

Medical observation and evaluation for suspected diseases and conditions

119

0.47

1.68

1.0

1.1

—

Other disorders of kidney and ureter

3.16

1.66

1.0

—

D07AA Corticosteroids, weak (group I)

3.16

1.66

1.2

1.0

—

Other disorders of ear

144

1.57

1.65

1.1

—

Kela-code for severe mental illness

2.10

1.65

1.4

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.80

1.65

1.1

1.0

—

Nonorganic sleeping disorders

2.80

1.65

1.7

1.0

—

Presbycusis

2.57

1.64

1.0

1.1

—

Papulosquamous disorders

1.97

1.64

1.0

1.1

—

Infections of the skin and subcutaneous tissue

119

1.76

1.63

1.1

—

Benzodiazepine use

172

1.53

1.62

1.2

1.1

—

Disorders of the thyroid gland

147

1.56

1.62

1.1

—

Acute suppurative otitis media

3.11

1.62

1.0

1.1

—

Fall on and from ladder

3.58

1.61

1.0

—

Normotensive glaucoma

3.58

1.61

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.96

1.61

1.1

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.14

1.60

1.1

1.0

—

Acute pancreatitis (for exclusion)

2.50

1.59

1.1

1.0

—

Other and unspecified iron deficiency

2.06

1.59

1.2

1.0

—

Episodal and paroxysmal disorders

131

1.53

1.59

1.1

—

Other bursopathies

3.00

1.58

1.2

1.0

—

Gonarthrosis

1.68

1.57

1.0

1.1

—

Congenital malformations of the circulatory system

3.46

1.56

1.0

—

Convulsions, not elsewhere classified

2.96

1.56

1.0

1.1

—

Umbilical hernia

2.11

1.54

1.1

1.0

—

Schizophrenia or delusion, excluding more controls

2.18

1.54

1.4

1.0

—

Effects of foreign body entering through natural orifice

0.00

1.52

0.0

1.0

—

Crohn disease

3.34

1.52

1.0

—

Presence of other devices

0.00

1.52

0.0

1.1

—

Type 2 diabetes, definitions combined

141

1.52

1.1

—

Other specific joint derangements/joint disorders

101

1.66

1.51

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.80

1.50

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

155

1.51

1.49

1.1

—

Conduction disorders

2.18

1.48

1.2

1.0

—

Type 2 diabetes, strict (exclude DM1)

142

1.51

1.48

1.1

—

Any reimbursement code in KELA

2.30

1.47

1.0

1.1

—

Spinal stenosis

102

1.69

1.46

1.0

1.1

—

Diabetes medication

150

1.50

1.46

1.1

—

Other arrhythmias

1.74

1.46

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

114

1.66

1.45

1.0

1.1

—

Psoriasis vulgaris

2.50

1.45

1.0

—

Sleep disorders

2.50

1.45

1.7

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.77

1.45

1.0

—

Other systemic involvement of connective tissue (FG)

2.35

1.44

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

173

1.49

1.44

1.2

1.1

—

Benign neoplasm: Caecum

3.13

1.44

1.0

—

Other disorders of penis

3.13

1.44

1.0

1.1

—

Diseases of the myoneural junction and muscle

3.13

1.44

1.2

1.0

—

Benign neoplasm of other and unspecified endocrine glands

3.13

1.44

1.0

—

TMD related operations

3.13

1.44

1.0

—

Other diseases of oesophagus

3.13

1.44

1.0

—

Mental and behavioural disorders due to psychoactive substance use

132

1.64

1.43

1.2

1.1

—

132

1.63

1.43

1.2

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.73

1.43

1.2

1.0

—

Appendicitis, broad definition

157

1.57

1.41

1.1

—

Diabetes, varying definitions

144

1.49

1.41

1.1

—

Mycoses

2.25

1.40

1.0

1.1

—

Fracture of lumbar spine and pelvis

2.25

1.39

1.2

1.0

—

Schizophrenia, schizotypal and delusional disorders

2.17

1.39

1.4

1.0

—

Diseases of appendix

157

1.57

1.39

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.85

1.39

1.0

—

Coxarthrosis

1.70

1.39

1.2

1.1

—

Angina pectoris

1.65

1.39

1.0

1.1

—

In situ neoplasms

1.89

1.38

1.0

1.1

—

Other hearing loss

2.00

1.37

1.1

—

Diabetes mellitus

145

1.48

1.36

1.1

—

Malignant neoplasm of breast, HER2-negative

1.87

1.36

1.2

1.1

—

Hard cardiovascular diseases

120

1.55

1.36

1.2

1.1

—

Other arthrosis

1.70

1.36

1.1

—

Amiodarone users

2.94

1.36

1.2

1.0

—

Seborrhoeic dermatitis

2.94

1.36

1.0

—

Noninfectious colitis NAS

2.94

1.36

1.2

1.0

—

Schizophrenia

2.94

1.36

1.8

1.0

—

Diseases of the ear and mastoid process

143

1.45

1.36

1.1

—

Pre-eclampsia or poor fetal growth

0.00

1.34

0.0

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.88

1.33

1.0

1.1

—

Disorders of choroid and retina

144

1.52

1.32

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

131

1.47

1.31

1.1

—

Myocardial infarction, without ST-elevation

1.74

1.31

1.0

1.1

—

Mixed conductive and sensorineural hearing loss

2.50

1.30

1.0

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

2.50

1.30

1.0

—

Open wound of wrist and hand

1.85

1.30

1.1

1.0

—

Concussion

1.78

1.29

1.1

—

Mouth breathing

1.84

1.29

1.1

—

Cardiomyopathies, Primary/intrinsic

2.78

1.28

1.2

1.0

—

Cardiomyopathy (excluding other)

2.78

1.28

1.2

1.0

—

Diseases of oesophagus, stomach and duodenum

160

1.44

1.28

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

150

1.44

1.27

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

141

1.47

1.27

1.0

1.1

—

Dental pulpitis 1

132

1.46

1.27

1.1

—

Dental pulpitis 4

132

1.46

1.27

1.1

—

Other systemic involvement of connective tissue

2.05

1.26

1.0

—

Urticaria

2.05

1.26

1.1

1.0

—

Nonsuppurative otitis media

2.47

1.26

1.0

—

Constipation

155

1.48

1.26

1.2

1.1

—

Pain in throat and chest

102

1.56

1.25

1.0

1.1

—

Hypertensive diseases (excluding secondary)

1.94

1.25

1.1

—

Other diseases of intestines

149

1.44

1.25

1.1

—

Myocardial infarction, with ST-elevation

2.22

1.24

1.4

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

2.22

1.24

1.0

—

Malignant neoplasm of breast

1.80

1.24

1.2

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

2.22

1.24

1.6

1.0

—

Erysipelas

1.70

1.22

1.1

—

Insulin, fast-acting

1.90

1.22

1.0

—

Other soft tissue disorders, not elsewhere classified

134

1.48

1.22

1.1

—

Deforming dorsopathies

2.04

1.21

1.1

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

2.63

1.21

1.6

1.0

—

Orchitis and epididymitis

2.63

1.21

1.2

1.1

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

2.63

1.21

1.0

1.1

—

Cerebrovascular diseases (FINNGEN)

2.20

1.21

1.0

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

2.63

1.21

1.0

1.1

—

Acute pancreatitis

2.16

1.21

1.1

1.0

—

Selective serotonin reuptake inhibitors

131

1.45

1.21

1.2

1.1

—

Other noninfective gastroenteritis and colitis

2.16

1.21

1.1

—

Acute upper respiratory infections

157

1.44

1.21

1.1

—

Anomalies of dental arch relationship, including avohilmo

2.64

1.20

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

2.14

1.20

1.0

—

Hyperlipidaemia, other/unspecified

1.72

1.20

1.0

1.1

—

Pain in limb

129

1.51

1.19

1.1

—

Unspecified mental disorder

1.83

1.19

1.4

1.1

—

Other and unspecified nerve root and plexus disorders, also in other diseases

2.31

1.18

1.2

1.0

—

Depression

151

1.46

1.18

1.2

1.1

—

Mood [affective] disorders

161

1.43

1.16

1.2

1.1

—

Disorders of skin appendages

1.77

1.16

1.0

1.1

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

1.16

0.0

1.0

—

Biguanides

146

1.44

1.14

1.1

—

Injuries to the head

171

1.41

1.14

1.1

—

Mood disorders

162

1.42

1.13

1.2

1.1

—

Carpal tunnel syndrome

114

1.58

1.11

1.2

1.1

—

Alcohol use disorder, Swedish definition

125

1.56

1.11

1.2

1.1

—

IBD patients in KELA-register

2.26

1.10

1.4

1.0

—

Hypertensive heart and/or renal disease

1.99

1.10

1.1

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

2.24

1.09

1.0

1.1

—

Nutritional anaemias

101

1.64

1.09

1.1

—

Missing teeth due to accident, extraction or parodontitis

2.38

1.09

1.0

—

Benign neoplasm of other and unspecified endocrine glands

2.38

1.09

1.0

—

Squamous cell neoplasms and carcinomas of the skin

2.38

1.09

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

0.48

1.08

1.0

1.1

—

Acute alcohol intoxication, ICD10

2.19

1.08

1.6

1.0

—

Otitis externa

2.19

1.08

1.0

—

Inflammatory bowel disease, strict (require KELA)

2.19

1.08

1.4

1.0

—

Acute appendicitis, no complications

104

1.63

1.08

1.2

1.1

—

Substance abuse

130

1.54

1.07

1.2

1.1

—

Complications of medical and surgical care

160

1.48

1.07

1.2

1.1

—

Substance abuse, excluding more controls

119

1.54

1.06

1.2

1.0

—

Cough

1.76

1.06

1.2

1.0

—

Coronary angioplasty

1.69

1.05

1.2

1.0

—

Mood disorders, excluding more controls

142

1.41

1.04

1.1

—

STROKE

1.59

1.04

1.0

1.1

—

Other disorders of the musculoskeletal system and connective tissue

2.27

1.03

1.2

1.0

—

Type 2 diabetes

144

1.40

1.03

1.1

—

Hypertensive Heart Disease

1.94

1.02

1.1

1.0

—

Other benign neoplasms of skin

1.83

1.01

1.0

—

Emergency coronary revascularization (for ACS)

110

1.50

1.01

1.1

—

Other (not insulin) diabetes medications

147

1.39

1.00

1.1

—

Antenatal screening

0.00

1.00

0.0

1.1

—

Insulin, fast-acting or short human

1.76

1.00

1.0

—

Enthesopathies of lower limb, excluding foot

2.00

1.00

1.1

—

Open wound of head

121

1.55

0.99

1.1

—

Paroxysmal tachycardia

2.22

0.99

1.2

1.0

—

Dementia in Alzheimer disease

2.00

0.99

1.1

—

Voice disturbances

1.84

0.98

1.0

—

Other disorders of veins

1.71

0.98

1.1

1.0

—

Gonarthrosis,primary

149

1.39

0.98

1.1

—

Diseases of external ear

1.80

0.98

1.1

1.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

2.18

0.98

1.2

1.0

—

Spondyloarthritis

2.17

0.98

1.2

1.0

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.95

0.97

1.0

—

Gestational [pregnancy-induced] hypertension

0.00

0.96

0.0

1.0

—

Hernia of abdominal wall

108

1.57

0.96

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

141

1.39

0.95

1.1

—

Disorders of lens

103

1.47

0.94

1.0

1.1

—

Acute alcohol intoxication

1.77

0.94

1.4

1.0

—

Other disorders of urethra and urinary system

117

1.47

0.94

1.2

1.1

—

Nontoxic multinodular goitre

1.89

0.94

1.0

—

Heart failure and coronary heart disease

1.70

0.93

1.1

—

Dysphagia

1.82

0.92

1.1

1.0

—

Nasal polyp

2.14

0.91

1.0

—

Pedal cyclist injured in transport accident

2.14

0.91

1.2

1.0

—

Injuries to the knee and lower leg

167

1.34

0.91

1.1

—

Myocardial infarction, strict

1.55

0.91

1.2

1.0

—

Diseases of liver

1.75

0.90

1.0

—

Endocrine, nutritional and metabolic diseases

1.49

0.90

1.0

1.1

—

Neoplasms

1.50

0.89

1.0

1.1

—

Suppurative and unspecified otitis media

1.92

0.89

1.0

1.1

—

Pain in joint

1.52

0.87

1.0

1.1

—

Use of pramipexole

1.86

0.87

1.1

1.0

—

Complications of labour and delivery

0.51

0.86

1.0

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

109

1.53

0.86

1.2

1.1

—

Antihypertensive medication - note that there are other indications

1.73

0.85

1.1

—

Spondylolisthesis/Spondylolysis

1.94

0.84

1.2

1.1

—

Rotator cuff syndrome

113

1.45

0.84

1.0

1.1

—

Gastro-oesophageal reflux disease

143

1.42

0.84

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

155

1.34

0.83

1.0

1.1

—

Other enthesopathies

1.75

0.83

1.2

1.0

—

Diabetic retinopathy, excluding more controls

1.82

0.83

1.1

1.2

—

Lumbar disc prolapse

115

1.45

0.83

1.1

—

Insulin medication

124

1.45

0.83

1.0

1.1

—

Symptoms and signs involving speech and voice

1.69

0.82

1.0

1.1

—

Mental and behavioural disorders due to alcohol

118

1.48

0.81

1.2

1.1

—

Disorders of parathyroid gland

1.85

0.80

1.0

1.1

—

Varicose veins

110

1.44

0.80

1.0

1.1

—

Other hammer toe(s) (acquired)

0.00

0.79

0.0

1.1

—

Foreign body on external eye

0.00

0.79

0.0

1.0

—

Fenamates

1.84

0.78

1.2

—

Injury of muscle and tendon at shoulder and upper arm level

1.59

0.78

1.0

1.1

—

Persons encountering health services for examination and investigation

119

0.67

0.77

1.0

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.74

0.77

1.0

1.1

—

Neurological diseases, wide definition

1.95

0.77

1.1

1.0

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

1.76

0.76

1.3

1.0

—

Pre-eclampsia or eclampsia

0.00

0.76

0.0

1.0

—

Medical abortion

0.53

0.75

1.0

1.1

—

Persons encountering health services in circumstances related to reproduction

0.55

0.74

1.2

1.1

—

Coxarthrosis, primary, with hip surgery

110

1.47

0.73

1.2

1.1

—

Shoulder lesions

122

1.36

0.73

1.0

1.1

—

Other symptoms and signs involving the digestive system and abdomen

2.00

0.72

1.4

1.0

—

Covid-19 suspected case

2.00

0.72

1.6

1.0

—

Abnormalities of heart beat

1.59

0.71

1.0

1.1

—

Primary open-angle glaucoma, strict

1.66

0.71

1.1

1.0

—

Intracranial injury

121

1.44

0.71

1.1

—

Other disorders of teeth and supporting structures

1.75

0.71

1.0

1.1

—

Injuries to the wrist and hand

171

1.31

0.71

1.0

1.1

—

Care involving use of rehabilitation procedures

127

1.42

0.71

1.2

1.1

—

Redundant prepuce, phimosis and paraphimosis

1.74

0.71

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

139

1.39

0.70

1.0

1.1

—

Other skin changes

1.92

0.70

1.0

—

Leisure time condition

1.92

0.70

1.2

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.43

0.70

1.0

1.1

—

Unspecified haematuria

1.49

0.70

1.1

—

Diseases of inner ear

115

1.45

0.70

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

1.71

0.70

1.1

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.71

0.70

1.1

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

126

1.43

0.69

1.0

1.1

—

Triptan medication for migraine, single purchase ok

1.41

0.69

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.41

0.69

1.1

—

Glaucoma

118

1.41

0.69

1.1

—

Fissure and fistula of anal and rectal regions

1.67

0.68

1.0

—

Other diseases of urinary system

148

1.29

0.67

1.1

—

132

1.39

0.67

1.2

1.1

—

Traumatic subdural haemorrhage

1.82

0.67

1.0

1.1

—

Diseases of middle ear and mastoid

1.48

0.67

1.0

—

Atopic dermatitis

0.53

0.67

1.0

1.1

—

Other dorsopathies, not elsewhere classified

125

1.31

0.66

1.2

1.1

—

Adenomyosis (Endometriosis of uterus)

1.79

0.66

1.2

1.1

—

Chronic periodontitis

1.79

0.66

1.0

—

Gonarthrosis, primary, with knee surgery

118

1.38

0.65

1.2

1.1

—

Other diseases of the digestive system

1.57

0.65

1.0

1.1

—

Deviated nasal septum

1.57

0.65

1.1

—

Injuries to the hip and thigh

1.46

0.64

1.1

—

Hydrocele

1.72

0.64

1.0

1.1

—

Primary gonarthrosis, bilateral

105

1.42

0.63

1.1

—

Diverticular disease of intestine

125

1.33

0.62

1.0

1.1

—

Parodontitis

165

1.30

0.62

1.0

1.1

—

Glaucoma suspect

1.52

0.62

1.0

—

Parodontitis or operation codes

165

1.29

0.62

1.0

1.1

—

Disorders of vestibular function (Vertigo)

1.46

0.62

1.1

1.0

—

Ventral hernia

1.63

0.62

1.1

1.0

—

GI-bleeding

1.55

0.62

1.0

1.1

—

Lichen planus, including avohilmo

1.67

0.61

1.0

—

Premature rupture of membranes

0.00

0.61

0.0

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.60

0.61

1.1

1.0

—

Maternal care for other known or suspected fetal problems

0.00

0.61

0.0

1.1

—

Pregnancy with abortive outcome

0.59

0.60

1.0

1.1

—

Undefined dementia

0.00

0.60

0.0

1.0

—

Unspecified dementia

0.00

0.60

0.0

1.0

—

Recurrent or chronic depression

1.52

0.60

1.2

1.0

—

Senile cataract

1.36

0.59

1.0

1.1

—

L02BB Anti-androgens

0.00

0.59

0.0

1.0

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.59

0.0

1.0

—

Unstable angina pectoris

1.45

0.58

1.1

—

Combinations of oral blood glucose lowering drugs

1.56

0.58

1.0

1.1

—

Pre-eclampsia

0.00

0.58

0.0

1.0

—

Colonic or urogenital fistula

1.51

0.58

1.0

—

Superficial injury of lower leg

1.71

0.57

1.2

1.0

—

Diabetic retinopathy, strict definition

1.70

0.57

1.2

1.0

—

Wet age-related macular degeneration

1.68

0.57

1.0

—

Gastric ulcer

1.67

0.56

1.2

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

148

0.67

0.56

1.1

—

Peripheral arterial reconstruction

1.62

0.55

1.0

—

Parodontitis and operation codes

165

1.27

0.53

1.0

1.1

—

Coxarthrosis, primary

131

1.33

0.53

1.2

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

108

1.39

0.52

1.3

1.0

—

Coronary artery bypass grafting

1.50

0.52

1.0

1.1

—

Glucosamine medication

1.37

0.51

1.1

—

Other extrapyramidal and movement disorders in other diseases

1.50

0.51

1.5

1.0

—

Other headache syndromes

1.49

0.49

1.1

1.0

—

Artificial joint operation, meniscal resection

161

1.24

0.48

1.1

—

Retention of urine

1.43

0.48

1.0

1.1

—

Visual disturbances and blindness

110

0.64

0.48

1.0

1.1

—

Primary open-angle glaucoma

1.45

0.48

1.1

—

Obesity

118

1.34

0.47

1.3

1.0

—

Type of accident

1.49

0.47

1.1

1.0

—

severe traumatic brain injury, does not include concussion

1.49

0.47

1.0

1.1

—

Artrosis, including avohilmo

118

1.26

0.47

1.0

1.1

—

Diseases of the digestive system

102

1.37

0.46

1.0

1.1

—

Arthrosis

1.29

0.46

1.0

1.1

—

Cardiovascular diseases

1.46

0.45

1.0

1.1

—

Abnormal serum enzyme levels

0.62

0.45

1.2

1.0

—

Complications of procedures, not elsewhere classified

165

1.26

0.45

1.2

1.1

—

Obesity and other hyperalimentation

119

1.33

0.45

1.3

1.0

—

Benign neoplasms

149

0.79

0.45

1.0

1.1

—

Hyperplasia of prostate

1.38

0.44

1.0

1.1

—

Meniscus derangement

1.32

0.44

1.1

—

Other external causes of accidental injury

104

1.25

0.44

1.0

1.1

—

Symptoms and signs involving the urinary system

148

1.25

0.44

1.0

1.1

—

Other anxiety disorders

1.45

0.44

1.4

1.0

—

Diseases of male genital organs

1.32

0.44

1.1

—

Other maternal disorders predominantly related to pregnancy

0.62

0.43

1.2

1.1

—

Atopic dermatitis, strict definition with reimbursement

1.62

0.43

1.0

—

Adhesive capsulitis of shoulder

1.61

0.43

1.0

—

Diseases of salivary glands

1.61

0.43

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.43

0.42

1.0

1.1

—

DVT of lower extremities

1.56

0.42

1.0

—

Benign neoplasm: Colon

136

0.72

0.41

1.0

1.1

—

Benign neoplasm: Stomach

0.00

0.41

0.0

1.0

—

Benign neoplasm of breast

0.00

0.41

0.0

1.1

—

Insulin, intermediate and long-acting

129

1.29

0.41

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.40

0.0

1.0

—

Other benign neoplasms of skin

1.39

0.40

1.0

1.1

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1.38

0.40

1.2

1.1

—

Cervicalgia

1.47

0.40

1.0

1.1

—

Type 1 diabetes

1.47

0.40

1.0

—

Hypertensive diseases

1.26

0.40

1.0

1.1

—

Hypertension

1.26

0.40

1.0

1.1

—

0.00

0.40

0.0

1.0

—

Other nutritional deficiencies

129

1.29

0.40

1.2

1.0

—

Benign neoplasm: Transverse colon

0.00

0.40

0.0

1.0

—

Other symptoms and signs involving the urinary system

0.00

0.40

0.0

1.0

—

Malignant melanoma of skin

0.00

0.40

0.0

1.0

—

Diplopia

0.00

0.40

0.0

1.0

—

Burns and corrosions

0.00

0.40

0.0

1.0

—

Alcohol use disorder, ICD-based

1.34

0.39

1.1

—

Other and unspecified effects of external causes

1.43

0.39

1.0

—

Falls/tendency to fall

138

1.20

0.39

1.1

—

Superficial injury of wrist and hand

0.00

0.39

0.0

1.0

—

Allergic rhinitis

1.41

0.39

1.4

1.0

—

Inguinal hernia

123

0.77

0.38

1.2

1.1

—

Other and unspecified polyneuropathies, also in other diseases

1.39

0.38

1.2

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.39

0.38

1.0

—

Diabetic retinopathy

1.39

0.38

1.1

—

Anti-inflammatory and antirheumatic products, non-steroids

0.64

0.37

1.0

1.2

—

Triptan medication for migraine, min. 3 purchases

1.38

0.37

1.2

1.0

—

Other disorders of lacrimal gland

1.32

0.37

1.0

—

Diseases of oral cavity, salivary glands and jaws

114

1.21

0.37

1.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.35

0.37

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.36

0.36

1.0

1.1

—

Dermatitis

134

1.27

0.36

1.2

1.0

—

Dental caries 3, only avohilmo

114

1.21

0.36

1.0

1.1

—

Chronic periodontitis, including avohilmo

166

1.20

0.36

1.0

1.1

—

Colorectal adenocarcinoma

1.43

0.35

1.3

1.0

—

Dental pulpitis 1, only avohilmo

141

1.18

0.35

1.1

—

Dental pulpitis 4, only avohilmo

141

1.18

0.35

1.1

—

Disorders of gallbladder, biliary tract and pancreas

163

1.19

0.35

1.1

—

Factors influencing health status and contact with health services

0.67

0.34

1.0

1.1

—

Other intervertebral disc disorders

121

1.21

0.34

1.1

—

Dental pulpitis 2

1.24

0.34

1.0

1.1

—

Cervical disc disorders

1.34

0.34

1.0

1.1

—

Other gastritis (incl. Duodenitis)

1.33

0.33

1.0

—

Cholecystectomy

144

1.23

0.33

1.1

—

Polyuria

1.30

0.33

1.0

1.1

—

Functional dyspepsia

1.30

0.33

1.2

1.0

—

Anxiety disorders

135

1.21

0.32

1.2

1.1

—

Unspecific neurodegenerative disorder

1.30

0.32

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

149

0.79

0.31

1.0

1.1

—

Sciatica+with lumbago

1.29

0.31

1.1

—

Benign paroxysmal vertigo

1.35

0.31

1.1

1.0

—

Alcohol dependence

1.35

0.31

1.0

—

Anxiety disorders, excluding more controls

127

1.20

0.31

1.2

1.1

—

Symptoms and signs involving the digestive system and abdomen

128

1.17

0.31

1.1

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1.33

0.31

1.3

1.0

—

Diseases of the eye and adnexa

1.21

0.30

1.0

1.1

—

Visual disturbances

100

0.70

0.30

1.0

—

Obesity, other/unspecified

1.30

0.30

1.3

1.0

—

Organic, including symptomatic, mental disorders

1.26

0.30

1.1

—

Actinic keratosis

1.29

0.30

1.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

1.29

0.29

1.0

1.1

—

Hypertension, essential

1.21

0.29

1.1

—

Disorders of vitreous body

109

1.26

0.29

1.0

—

Nontoxic goitre/thyroid nodule

1.23

0.29

1.0

1.1

—

Spontaneous abortion

1.33

0.28

1.1

—

Hallux valgus (acquired)

1.32

0.28

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.26

0.28

1.1

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.27

0.28

1.0

1.2

—

Depression or dysthymia

103

1.20

0.28

1.0

—

Other joint disorders

103

1.19

0.28

1.0

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

122

1.18

0.28

1.1

—

Any mental disorder

146

0.86

0.27

1.0

1.1

—

Neurological diseases

1.18

0.26

1.0

1.1

—

Migraine

1.25

0.25

1.1

1.0

—

Transient ischemic attack

109

1.22

0.25

1.0

1.1

—

Genitourinary diseases

1.22

0.25

1.0

1.1

—

Acetic acid derivatives and related substances

1.20

0.25

1.0

1.2

—

Other diseases of hard tissues of teeth

105

1.21

0.25

1.1

—

Other and unspecified disorders of vitreous body

1.27

0.25

1.0

1.1

—

Alzheimer disease, including avohilmo

0.70

0.24

1.0

1.1

—

Disorders of breast

0.73

0.24

1.0

1.1

—

Diaphragmatic hernia

0.72

0.24

1.2

1.0

—

Injuries to the elbow and forearm

129

1.19

0.23

1.1

—

Superficial injury of head

1.32

0.23

1.0

—

Other and unspecified dermatitis

106

1.23

0.23

1.2

1.0

—

Dorsopathies

125

1.14

0.23

1.0

1.1

—

Erosion of teeth, including avohilmo

1.27

0.22

1.0

—

Injuries to the ankle and foot

122

1.19

0.22

1.1

—

Seborrhoeic keratosis

1.25

0.22

1.0

—

Accidents

104

1.16

0.22

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

135

1.16

0.22

1.2

1.1

—

Disorders of vitreous body and globe

113

1.21

0.22

1.0

1.1

—

Dental caries 2 and operation codes, only avohilmo

111

0.84

0.22

1.3

1.1

—

Unspecified fall

106

1.22

0.21

1.2

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.22

0.21

1.0

1.1

—

Cyst of kidney

0.00

0.21

0.0

1.0

—

Hydrocephalus

0.00

0.21

0.0

1.0

—

Acute gastritis

0.00

0.21

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.21

0.0

1.0

—

Unspecified urinary incontinence

0.00

0.21

0.0

1.1

—

Benign neoplasm: Stomach

0.00

0.21

0.0

1.0

—

Burns and corrosions of external body surface, specified by site

0.00

0.21

0.0

1.0

—

LSIL lesion of the cervix uteri

0.00

0.21

0.0

1.0

—

Conjunctivitis (acute, non atopic)

1.19

0.21

1.2

1.0

—

1.23

0.21

1.0

1.1

—

conjunctival haemorrhage

0.00

0.21

0.0

1.0

—

Focal brain injury

0.00

0.21

0.0

1.0

—

Benign neoplasm: Transverse colon

0.00

0.21

0.0

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

1.0

—

Other disorders of amniotic fluid and membranes

0.00

0.21

0.0

1.0

—

Tooth eruption problems

0.00

0.21

0.0

1.1

—

Other disorders of eyelid

0.79

0.21

1.0

1.1

—

Other noninflammatory disorders of vagina

0.00

0.21

0.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.21

0.0

1.0

—

Dental caries 1, only avohilmo

107

1.15

0.20

1.0

1.1

—

Sequelae of cerebrovascular disease

1.25

0.20

1.0

1.1

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1.24

0.20

1.0

1.1

—

Soft tissue disorders related to use, overuse and pressure

1.25

0.20

1.3

1.0

—

Dizziness and giddiness

152

0.85

0.20

1.3

1.1

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.20

0.0

1.0

—

Injuries to the shoulder and upper arm

169

1.14

0.20

1.0

1.1

—

Colorectal cancer

1.22

0.20

1.3

1.0

—

Disorders of sclera, cornea, iris and ciliary body

114

0.79

0.20

1.1

1.0

—

Fibroblastic disorders

1.20

0.19

1.0

—

Stroke, excluding SAH

115

1.16

0.19

1.0

1.1

—

Cystitis

124

1.13

0.18

1.1

—

Arthropathies

103

1.14

0.18

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.14

0.18

1.0

1.1

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1.22

0.18

1.0

1.1

—

Cerebrovascular diseases

139

1.13

0.17

1.0

1.1

—

Female genital prolapse

0.76

0.17

1.0

1.1

—

Extrapyramidal and movement disorders

1.22

0.17

1.4

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

138

1.15

0.16

1.3

1.1

—

Primary coxarthrosis, bilateral

0.71

0.16

1.2

1.0

—

Fall on same level involving ice and snow

120

0.83

0.16

1.1

—

Endometriosis

1.13

0.16

1.1

—

Propionic acid derivatives

0.77

0.16

1.0

1.2

—

Dementia, including avohilmo

1.18

0.16

1.0

1.1

—

Urolithiasis

1.11

0.16

1.3

1.0

—

Dental pulpitis 2, only avohilmo

1.13

0.16

1.0

1.1

—

Malignant neoplasm of prostate

0.85

0.15

1.0

1.1

—

Tonsillectomy and adenotomy

1.14

0.15

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

172

0.90

0.15

1.2

1.1

—

Dental caries 3 and operation codes, only avohilmo

0.78

0.15

1.0

—

Dental operations

1.14

0.15

1.0

1.1

—

Gastrointestinal diseases

0.84

0.15

1.0

1.1

—

Hernia

166

1.10

0.15

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

119

0.89

0.15

1.0

1.1

—

malignant neoplasm of male genital organs

0.86

0.14

1.0

1.1

—

Ischaemic Stroke, excluding all haemorrhages

113

1.14

0.14

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

146

1.13

0.14

1.1

—

Other diseases of upper respiratory tract

153

1.09

0.14

1.1

—

Dental caries 1 and operation codes

116

1.11

0.13

1.0

1.1

—

Statin medication

0.87

0.13

1.0

1.1

—

Conjunctivitis

123

1.13

0.13

1.1

—

Dementia

1.17

0.13

1.0

1.1

—

Stroke, including SAH

127

1.11

0.11

1.0

1.1

—

Disorders of lacrimal system

1.16

0.11

1.0

—

Fall on and from stairs and steps

1.14

0.10

1.2

1.0

—

Dental caries 3

113

1.09

0.10

1.0

1.1

—

Disorders of synovium and tendon

103

0.87

0.10

1.1

—

Peripheral artery disease

1.12

0.09

1.0

—

Other functional intestinal disorders

1.14

0.09

1.4

1.1

—

Dermatitis and eczema

183

0.93

0.09

1.2

1.1

—

Other reaction to severe stress, and adjustment disorders

1.04

0.09

1.0

—

Other degenerative diseases of the nervous system

1.11

0.09

1.0

1.1

—

Fracture of femur

1.12

0.09

1.3

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.11

0.09

1.5

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

108

1.12

0.09

1.0

1.1

—

Leiomyoma of uterus

1.06

0.09

1.0

1.1

—

Postmenopausal bleeding

0.81

0.08

1.0

1.1

—

Vasomotor and allergic rhinitis

1.06

0.08

1.3

1.0

—

Soft tissue disorders

136

1.07

0.08

1.0

1.1

—

Abrasion of teeth

1.09

0.08

1.1

1.0

—

Polyp of the female genital tract

1.07

0.08

1.0

1.1

—

Diseases of the musculoskeletal system and connective tissue

0.88

0.08

1.0

1.1

—

Menorrhagia

0.83

0.08

1.0

1.1

—

Ovarian cyst

0.85

0.08

1.0

1.1

—

Haemorrhoids and perianal venous thrombosis

0.84

0.07

1.0

1.1

—

Retinal detachments and breaks

0.81

0.07

1.0

1.1

—

Noninflammatory disorders of female genital tract

0.84

0.07

1.0

1.1

—

Internal derangement of knee

1.02

0.07

1.1

—

Degenerative diseases of the nervous system

0.82

0.07

1.0

1.1

—

Obesity due to excess calories

1.06

0.07

1.3

1.0

—

Any dementia, excluding more controls

0.87

0.07

1.0

1.1

—

Sulfonylureas

0.88

0.06

1.1

—

Transport accidents

0.89

0.06

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.12

0.06

1.1

1.0

—

Anxiety (asthma-related co-morbidities)

1.10

0.05

1.3

1.1

—

All anxiety disorders

1.10

0.05

1.3

1.0

—

Dental caries, including avohilmo

106

1.06

0.05

1.0

1.1

—

Dental caries 1

106

1.06

0.05

1.0

1.1

—

Dental caries 3 and operation codes

122

1.05

0.04

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

1.07

0.04

1.0

1.1

—

Gingivitis and periodontal diseases

113

1.05

0.04

1.0

1.1

—

Benign neoplasms

0.93

0.03

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

164

0.96

0.03

1.0

1.1

—

Leiomyoma of uterus

0.93

0.02

1.0

1.1

—

Cholelithiasis

149

1.04

0.01

1.0

1.1

—

Exposure to other specified factors

153

1.04

0.01

1.2

1.1

—

Psychiatric diseases

139

0.97

0.01

1.0

1.1

—

Parodontitis or/and operation codes

0.96

0.01

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

136

0.96

0.01

1.2

1.1

—

Other neurological diseases

148

1.03

0.00

1.0

1.1

—

Polycystic ovarian syndrome, consortium definition

0.95

0.00

1.0

1.1

—

Chronic diseases of tonsils and adenoids

105

0.96

0.00

1.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.05

0.00

1.0

—

Dental caries 2

121

0.97

0.00

1.3

1.1

—

Abnormal findings on examination of blood, without diagnosis

118

1.03

0.00

1.3

1.1

—

Fracture of forearm

1.05

0.00

1.2

1.1

—

Fracture of lower leg, including ankle

115

1.04

0.00

1.1

1.0

—

Inflammatory diseases of female pelvic organs

0.97

0.00

1.1

—

Presence of cardiac and vascular implants and grafts

0.99

0.00

1.0

1.1

—

Dental operations, only avohilmo

1.01

0.00

1.0

1.1

—

Dental caries 2, only avohilmo

116

1.02

0.00

1.3

1.1

—

Cholelithiasis, broad definition with cholecystitis

153

0.99

0.00

1.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

100

1.03

0.00

1.2

1.0

—

Abdominal and pelvic pain

128

0.98

0.00

1.1

—

Pure hypercholesterolaemia

117

0.97

0.00

1.2

1.1

—

Benign neoplasm: Colon

1.05

0.00

1.0

1.1

—

Disorders of conjunctiva

140

1.02

0.00

1.1

—

Malignant neoplasm of digestive organs

1.06

0.00

1.2

1.0

—

Dental caries 2 and operation codes

117

1.02

0.00

1.3

1.1

—

Allergic conjunctivitis

1.04

0.00

1.1

—

External causes of morbidity and mortality

1.00

0.00

1.0

1.1

—

Speech and linguistic disorders

0.00

0.0

1.1

—

Benign neoplasm of breast

0.00

0.0

1.0

—

Striking against or struck by other objects

0.96

0.00

1.0

—

Dementia due to Parkinsons disease, excluding more controls

0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.0

1.0

—

Unspecified jaundice

0.00

0.0

1.0

—

Calculus of kidney and ureter

0.90

0.00

1.0

—

Twin gestation

0.00

0.0

1.0

—

Use of ropinirole

0.00

0.0

1.0

—

Cerebral aneurysm, nonruptured

0.00

0.0

1.0

—

Other and unspecified visual disturbances

0.00

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

0.0

1.0

—

Crowding of teeth, including avohilmo

0.00

0.0

1.2

—

Other and/or unspecified nontoxic goitre

0.00

0.0

1.0

—

Ocular pain

0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.0

1.0

—

Any dementia

0.98

0.00

1.0

1.1

—

Preparatory care for dialysis

0.00

0.0

1.0

—

Haemangioma, any site

0.00

0.0

1.0

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.0

—

Chronic suppurative otitis media, including avohilmo

0.00

0.0

1.0

—

Keratitis

0.94

0.00

1.0

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

0.0

1.0

—

Other diseases of anus and rectum

0.91

0.00

1.0

1.1

—

Right bundle-branch block

0.00

0.0

1.0

—

Traumatic amputation of wrist and hand

0.00

0.0

1.0

—

0.00

0.0

1.0

—

Blepharochalasis

0.87

0.00

1.0

1.1

—

Abnormalities of forces of labour

0.00

0.0

1.0

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Viral hepatitis

0.00

0.0

1.0

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.0

—

Artificial opening status

0.00

0.0

1.0

—

Paralytic strabismus

0.00

0.0

1.0

—

N06DA Anticholinesterases

0.95

0.00

1.0

1.1

—

Spirochaetal infections, other/unspecified

0.00

0.0

1.0

—

Other disorders of nervous system

0.00

0.0

1.0

—

Haemangioma, any site

0.00

0.0

1.0

—

Other problems related to primary support group, including family circumstances

0.00

0.0

1.0

—

Benign neoplasm: Choroid

0.00

0.0

1.0

—

Coxibs

0.96

0.00

1.0

1.2

—

Polyhydramnios

0.00

0.0

1.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.0

1.0

—

Flat foot [pes planus] (acquired)

0.00

0.0

1.3

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri

0.00

0.0

1.0

—

Vasomotor rhinitis (mode)

0.00

0.0

1.0

—

Polypectomy (DHB20)

0.00

0.0

1.0

—

Excessive vomiting in pregnancy

0.00

0.0

1.0

—

Foreign body in alimentary tract

0.00

0.0

1.0

—

Acne

0.00

0.0

1.0

—

Disorders of psychological development

0.00

0.0

1.1

—

Inflammatory disease of cervix uteri

0.00

0.0

1.0

—

UC patients in KELA-register (code 208), prior to 1994

0.00

0.0

1.0

—

Use of selegiline

0.00

0.0

1.0

—

Contusion of other and unspecified parts of foot

0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Epilepsy

0.94

0.00

1.0

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri

0.00

0.0

1.0

—

Examination and encounter for administrative purposes

0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.0

—

Use of anticholinesterases

0.95

0.00

1.0

1.1

—

Use of memantine

0.89

0.00

1.2

1.1

—

Stomatitis and related lesions

0.00

0.0

1.0

—

Status post-ami

0.00

0.0

1.1

—

Alzheimer disease

0.98

0.00

1.0

1.1

—

Normal-pressure hydrocephalus

0.00

0.0

1.0

—

Excessive attrition of teeth

0.90

0.00

1.0

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.0

1.0

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.0

1.1

—

Type1 diabetes, definitions combined, early onset

0.00

0.0

1.0

—

Superficial injury of forearm

0.00

0.0

1.0

—

Other or ill-defined heart diseases

0.00

0.0

1.0

—

Oral leukoplakia and related diseases

0.00

0.0

1.0

—

Use of other anti-dementia drugs

0.89

0.00

1.2

1.1

—

Embedded teeth, including avohilmo

0.00

0.0

1.0

—

Excessive, frequent and irregular menstruation

0.93

0.00

1.0

1.1

—

Poor fetal growth

0.00

0.0

1.0

—

Specific development disorders of speech and language

0.00

0.0

1.2

—

Special screening examination for neoplasms

0.00

0.0

1.0

—

Elevated blood glucose level

0.00

0.0

1.0

—

Somnolence, stupor and coma

0.00

0.0

1.0

—

Family history of malignant neoplasm

0.00

0.0

1.0

—

Barrett oesophagus

0.00

0.0

1.0

—

Mixed hyperlipidaemia

0.00

-0.00

0.0

1.0

—

Other specified/unspecified hearing loss

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Legionella sp Ag [Presence] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS